GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (FRA:01P) » Definitions » Cyclically Adjusted PB Ratio

Medpace Holdings (FRA:01P) Cyclically Adjusted PB Ratio : 20.33 (As of Jun. 10, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Medpace Holdings's current share price is €371.30. Medpace Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €18.26. Medpace Holdings's Cyclically Adjusted PB Ratio for today is 20.33.

The historical rank and industry rank for Medpace Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:01P' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 18.87   Med: 19.94   Max: 20.36
Current: 20.36

During the past years, Medpace Holdings's highest Cyclically Adjusted PB Ratio was 20.36. The lowest was 18.87. And the median was 19.94.

FRA:01P's Cyclically Adjusted PB Ratio is ranked worse than
97.08% of 137 companies
in the Medical Diagnostics & Research industry
Industry Median: 2 vs FRA:01P: 20.36

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medpace Holdings's adjusted book value per share data for the three months ended in Mar. 2024 was €19.940. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €18.26 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medpace Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Medpace Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Cyclically Adjusted PB Ratio Chart

Medpace Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medpace Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 20.51

Competitive Comparison of Medpace Holdings's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Medpace Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medpace Holdings's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Cyclically Adjusted PB Ratio falls into.



Medpace Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Medpace Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=371.30/18.26
=20.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medpace Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Medpace Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=19.94/131.7762*131.7762
=19.940

Current CPI (Mar. 2024) = 131.7762.

Medpace Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.000 98.326 0.000
201403 0.000 99.695 0.000
201412 8.226 99.070 10.942
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 9.578 99.792 12.648
201603 9.466 100.470 12.416
201606 9.489 101.688 12.297
201609 13.360 101.861 17.284
201612 14.238 101.863 18.419
201703 14.274 102.862 18.286
201706 13.618 103.349 17.364
201709 12.343 104.136 15.619
201712 11.997 104.011 15.200
201803 11.674 105.290 14.611
201806 13.006 106.317 16.121
201809 13.519 106.507 16.726
201812 14.533 105.998 18.067
201903 15.404 107.251 18.927
201906 16.225 108.070 19.784
201909 17.448 108.329 21.224
201912 18.124 108.420 22.028
202003 18.307 108.902 22.152
202006 18.510 108.767 22.426
202009 18.796 109.815 22.555
202012 18.647 109.897 22.359
202103 20.083 111.754 23.681
202106 19.740 114.631 22.692
202109 21.241 115.734 24.185
202112 23.422 117.630 26.239
202203 16.325 121.301 17.735
202206 8.647 125.017 9.115
202209 11.363 125.227 11.957
202212 11.731 125.222 12.345
202303 10.591 127.348 10.959
202306 11.810 128.729 12.090
202309 14.381 129.860 14.593
202312 16.667 129.419 16.971
202403 19.940 131.776 19.940

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medpace Holdings  (FRA:01P) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Medpace Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medpace Holdings (FRA:01P) Business Description

Traded in Other Exchanges
Address
5375 Medpace Way, Cincinnati, OH, USA, 45227
Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.

Medpace Holdings (FRA:01P) Headlines

No Headlines